Oncology

Showing   of 64 results

International Harrington Prize Jointly Awarded to Drs. Arul Chinnaiyan and Charles Sawyers

2026 Harrington Prize for Innovation in Medicine recognizes pioneering work in prostate cancer diagnosis and treatment.

Thumbnail image of Reshmi Parameswaran.

Researchers Develop Promising New Therapy for Most Common Form of Bone Cancer in Children and Young Adults

Study published in BMC Medicine.

Thumbnail image of Seidman Cancer Center patient ringing her last treatment bell.

UH Awarded Once Again for Exceptional Cardiovascular Care of Patients Undergoing Cancer Treatment

International Cardio-Oncology Society grants highest designation.

Thumbnail image of Dr. Nicholas Zaorsky.

UH Seidman Cancer Researchers: What is the ideal duration of hormone therapy for the treatment of prostate cancer?

Results published in JAMA Oncology.

Thumbnail image of Dr. Soumayajit Roy.

University Hospitals Seidman Cancer Center Researchers Develop Easy-to-Use Tool that can Identify High- and Low-Risk Metastatic Prostate Cancer Patients Earlier

Results published in Nature Communications.

THumbnail image of Dr. Daniel Spratt, UH Seidman Cancer Center.

Randomized Clinical Trial Led by University Hospitals Seidman Cancer Center Oncologist Leads to Practice-Changing Precision Prostate Cancer Therapy

Randomized trial validates first biomarker tool to guide hormone treatment decisions, allowing for more personalized prostate cancer care.

Thumbnail image of a man holding his electric guitar in a patient room.

Pilot Study Provides Foundation for Understanding How Music Therapy Improves Pain After Pancreatic Surgery

A new study from University Hospitals Connor Whole Health found that it was feasible to conduct a live music-assisted relaxation and imagery session among patients admitted for pancreatic surgery.

Thumbnail image of Dr. John Letterio.

David’s Warriors St. Baldrick’s Research Grant Awarded to UH Rainbow Physician Researcher for Pediatric Neuroblastoma Study

The grant will support Dr. John Letterio’s project titled, “Development of a Novel NF-κB Targeting Agent for Pediatric Neuroblastoma” focused on improving treatment outcomes for children with high-risk neuroblastoma.

Results are loading...